Cargando…

Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium Mobilization in Female Rats

Atypical antipsychotics, such as olanzapine, are commonly prescribed to patients with schizophrenic symptoms and other psychiatric disorders. However, weight gain and metabolic disturbance cause adverse effects, impair patient compliance and limit clinical utility. Thus, a better understanding of tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ching-Ping, Wang, Ya-Yu, Lin, Shih-Yi, Hong, Yi-Jheng, Liao, Keng-Ying, Hsieh, Sheng-Kuo, Pan, Ping-Ho, Chen, Chun-Jung, Chen, Wen-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387243/ https://www.ncbi.nlm.nih.gov/pubmed/30717287 http://dx.doi.org/10.3390/ijms20030640

Ejemplares similares

Dysmetabolism and Neurodegeneration: Trick or Treat?
por: Capucho, Adriana M., et al.
Publicado: (2022)

Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia
por: Lu, Mong-Liang, et al.
Publicado: (2016)

Clinical significance of cardiovascular dysmetabolic syndrome
por: Deedwania, Prakash C
Publicado: (2002)

Dissecting cytosine methylation mechanics of dysmetabolism
por: Cencioni, Chiara, et al.
Publicado: (2019)

Inflammation and Dysmetabolism in Systemic Autoimmune Diseases
por: Afeltra, Antonella, et al.
Publicado: (2019)

Possible dysmetabolic hyperferritinemia in hyperinsulinemic horses
por: Kellon, Eleanor M., et al.
Publicado: (2019)

Determination of Olanzapine and N-desmethyl-olanzapine in Plasma Using a Reversed-Phase HPLC Coupled with Coulochemical Detection: Correlation of Olanzapine or N-desmethyl-olanzapine Concentration with Metabolic Parameters
por: Lu, Mong-Liang, et al.
Publicado: (2013)

Immune aging, dysmetabolism, and inflammation in neurological diseases
por: Deleidi, Michela, et al.
Publicado: (2015)

Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
por: Makker, Jasbir, et al.
Publicado: (2015)

Lipid and Bile Acid Dysmetabolism in Crohn's Disease
por: Uchiyama, Koji, et al.
Publicado: (2018)

Correction: Dissecting cytosine methylation mechanics of dysmetabolism
por: Cencioni, Chiara, et al.
Publicado: (2019)

White matter injury, cholesterol dysmetabolism, and APP/Abeta dysmetabolism interact to produce Alzheimer’s disease (AD) neuropathology: A hypothesis and review
por: Sharp, Frank R., et al.
Publicado: (2023)

The effect of maternal chromium status on lipid metabolism in female elderly mice offspring and involved molecular mechanism
por: Zhang, Qian, et al.
Publicado: (2017)

Friedreich ataxia: metal dysmetabolism in dorsal root ganglia
por: Koeppen, Arnulf H, et al.
Publicado: (2013)

Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia
por: Yang, Fuyin, et al.
Publicado: (2018)

Single-crystalline chromium silicide nanowires and their physical properties
por: Hsu, Han-Fu, et al.
Publicado: (2015)

Influence of Maternal Dysmetabolic Conditions During Pregnancy on Cardiovascular Disease
por: Palinski, Wulf, et al.
Publicado: (2009)

Synergistic action of inflammation and lipid dysmetabolism on kidney damage in rats
por: Wang, Zhongjie, et al.
Publicado: (2018)

Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer
por: Brisotto, Giulia, et al.
Publicado: (2020)

Thyroid Dysfunction and Dysmetabolic Syndrome: The Need for Enhanced Thyrovigilance Strategies
por: Kalra, Sanjay, et al.
Publicado: (2021)

Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer’s Disease
por: Aaseth, Jan, et al.
Publicado: (2021)

New insights into renal lipid dysmetabolism in diabetic kidney disease
por: Mitrofanova, Alla, et al.
Publicado: (2021)

The Role of Cellular Stress in Intrauterine Growth Restriction and Postnatal Dysmetabolism
por: Oke, Shelby L., et al.
Publicado: (2021)

Cholesterol Dysmetabolism in Alzheimer’s Disease: A Starring Role for Astrocytes?
por: Staurenghi, Erica, et al.
Publicado: (2021)

The Role of Tryptophan Dysmetabolism and Quinolinic Acid in Depressive and Neurodegenerative Diseases
por: Hestad, Knut, et al.
Publicado: (2022)

New Insights into the Neurodegeneration Mechanisms Underlying Riboflavin Transporter Deficiency (RTD): Involvement of Energy Dysmetabolism and Cytoskeletal Derangement
por: Colasuonno, Fiorella, et al.
Publicado: (2022)

Neuroprotective effects of olanzapine against rotenone-induced toxicity in PC12 cells
por: Xiong, Ya-jie, et al.
Publicado: (2020)

Flavonoids from Mulberry Leaves Alleviate Lipid Dysmetabolism in High Fat Diet-Fed Mice: Involvement of Gut Microbiota
por: Zhong, Yinzhao, et al.
Publicado: (2020)

Left ventricular diastolic dysfunction in nonhuman primate model of dysmetabolism and diabetes
por: Gu, Haihua, et al.
Publicado: (2015)

Amyloid Dysmetabolism Relates to Reduced Glucose Uptake in White Matter Hyperintensities
por: Kalheim, Lisa Flem, et al.
Publicado: (2016)

Mitochondrial and Peroxisomal Alterations Contribute to Energy Dysmetabolism in Riboflavin Transporter Deficiency
por: Colasuonno, Fiorella, et al.
Publicado: (2020)

Vanillin modulates activities linked to dysmetabolism in psoas muscle of diabetic rats
por: Salau, Veronica F., et al.
Publicado: (2021)

Multiomics Profiling Reveals Signatures of Dysmetabolism in Urban Populations in Central India
por: Monaghan, Tanya M., et al.
Publicado: (2021)

Achilles Tendon Rupture and Dysmetabolic Diseases: A Multicentric, Epidemiologic Study
por: Oliva, Francesco, et al.
Publicado: (2022)

Dysmetabolism-related Early Sensory Deficits and Their Relationship With Peripheral Neuropathy Development
por: Tsilingiris, Dimitrios, et al.
Publicado: (2023)

Maternal Obesity Related to High Fat Diet Induces Placenta Remodeling and Gut Microbiome Shaping That Are Responsible for Fetal Liver Lipid Dysmetabolism
por: Wang, Ying-Wen, et al.
Publicado: (2021)

Olanzapine induced autophagy through suppression of NF‐κB activation in human glioma cells
por: Zhu, Ying, et al.
Publicado: (2019)

Lack of Ovarian Secretions Reverts the Anabolic Action of Olanzapine in Female Rats
por: Skrede, Silje, et al.
Publicado: (2017)

One-Year Treatment with Olanzapine Depot in Female Rats: Metabolic Effects
por: Ersland, Kari M, et al.
Publicado: (2019)

Olanzapine–valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese population group
por: Xu, Lei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qnt87vc74h956s6uvte9bp92e4